Search

everythinglearnresearchcommunity

for

Search:↓

Platelet-rich plasma (PRP) is a safe and potentially effective way to treat hair loss, especially when combined with minoxidil.

The conclusion is that primary scarring alopecia is a complex condition that requires early and accurate diagnosis for effective treatment.

Overweight smokers have worse hair loss.

Hair and serum levels of zinc, copper, and iron are similar in people with alopecia areata and healthy individuals.

Horizontal scalp biopsy sections are better for diagnosing alopecia areata, showing fewer hair follicles and more miniaturized hairs.

Mice with autoimmune hair loss showed signs of heart problems.

Superficial cryotherapy is effective and safe for treating alopecia areata, with better results when used early and frequently.

Alopecia areata has a complex genetic basis that was not fully understood as of 2001.

Platelet-Rich Plasma (PRP) could potentially help regrow hair in people with Alopecia Areata, but more research is needed to confirm its effectiveness.

Advanced therapies like gene, cell, and tissue engineering show promise for hair regrowth in alopecia, but their safety and effectiveness need more verification.

PRP therapy and minoxidil combo works best for male hair loss.

Genomic approach finds new possible treatments for hair loss.

Non-obese women with hair loss have higher heart disease risk.

Targeting immune tolerance issues in Alopecia Areata could restore hair growth and maintain remission.

Low vitamin D levels are common in people with Alopecia Areata.

Topical diphencyprone helped regrow hair in mice and rats with a condition similar to human hair loss.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

Greying hairs may be protected from alopecia areata.

Possible link between androgens and COVID-19 severity; more research needed.

Both topical calcipotriol and narrowband UVB improved alopecia, but combining them didn't enhance the effect on hair loss severity, despite higher vitamin D3 levels.

Most patients with frontal fibrosing alopecia are middle-aged women, often have thyroid disease, and some treatments can help stabilize the condition.

Scientists have found specific genes linked to different hair loss conditions, which could lead to new treatments.

Scalp areas that look normal in people with hair loss may still show signs of disease under a microscope.

Herbs might help with hair loss, but more research is needed to confirm their safety and effectiveness.

Fluconazole can cause hair loss, but the exact cause is unknown.

The R343H mutation in the VDR gene causes vitamin D-resistant rickets with alopecia by impairing specific gene activity.

A man lost all his hair as a rare side effect after hepatitis C treatment.

Adding antihistamines to topical corticosteroid and cryotherapy may improve hair regrowth in alopecia areata patients.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

Poor response to topical immunotherapy in alopecia areata patients is linked to impaired cell responses.